about
Review: dermatitis herpetiformisMolecular diagnosis in autoimmune skin blistering conditionsImmune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodiesDiagnostic pathways and clinical significance of desquamative gingivitisImmunopathology and molecular diagnosis of autoimmune bullous diseasesPrevalence of pemphigus and pemphigoid autoantibodies in the general populationInhibition of Rho A activity causes pemphigus skin blistering.Autoimmune bullous disorders.The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease.Mucous membrane pemphigoid with generalized blisters: IgA and IgG autoantibodies target both laminin-332 and type XVII collagen.Follicular helper T Cells (Tfh) and IL-21 involvement in the pathogenesis of bullous pemphigoid.Quality of Life Assessment in Korean Patients with PemphigusThe desmosome and pemphigus.The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseasesExperimental models of epidermolysis bullosa acquisita.The Prevalence of S. aureus Skin and Soft Tissue Infections in Patients with PemphigusThe concept of autoimmune pancreatitis and its immunological backgrounds.Development of an ELISA for sensitive and specific detection of IgA autoantibodies against BP180 in pemphigoid diseases.Type XVII collagen (BP180) can function as a cell-matrix adhesion molecule via binding to laminin 332.IgG4 autoantibodies induce dermal-epidermal separationPemphigus IgG causes skin splitting in the presence of both desmoglein 1 and desmoglein 3.Detection of autoantibodies against recombinant desmoglein 1 and 3 molecules in patients with pemphigus vulgaris: correlation with disease extent at the time of diagnosis and during follow-up.Salivary Samples for the Diagnosis of Pemphigus vulgaris Using the BIOCHIP Approach: a Pilot Study.A case of lichen planus pemphigoides with autoantibodies to the NC16a and C-terminal domains of BP180 and to desmoglein-1.Inhibition of FAK prevents blister formation in the neonatal mouse model of pemphigus vulgaris.Circulating levels of mannan-binding lectin (MBL) and MBL-associated serine protease 2 in endemic pemphigus foliaceus.Evaluation of anti-desmoglein-1 and anti-desmoglein-3 autoantibody titers in pemphigus patients at the time of the initial diagnosis and after clinical remission.Autoantibody-induced intestinal inflammation and weight loss in experimental epidermolysis bullosa acquisita.Burden of disease during quiescent periods in patients with pemphigus.Interleukin-10-producing B-cells in autoimmune bullous diseases.Association Between Pemphigus and Neurologic Diseases.Coexistent Solid Malignancies in Pemphigus: A Population-Based Study.Plakoglobin-dependent disruption of the desmosomal plaque in pemphigus vulgaris.Pathogenicity of IgG in patients with IgG4-related disease.The health impact of pemphigus vulgaris and pemphigus foliaceus assessed using the Medical Outcomes Study 36-item short form health survey questionnaire.Neural nitric oxide synthase participates in pemphigus vulgaris acantholysis through upregulation of Rous sarcoma, mammalian target of rapamycin and focal adhesion kinase.Granzyme B is elevated in autoimmune blistering diseases and cleaves key anchoring proteins of the dermal-epidermal junction.Genetic identification and functional validation of FcγRIV as key molecule in autoantibody-induced tissue injuryFogo selvagem: endemic pemphigus foliaceus
P2860
Q27008816-5D4D3BA7-B193-47BB-BB62-D679050CCEFCQ27025483-4902B516-C91D-4E0B-95B7-DA8DA5BEA76BQ28069362-20451621-CD33-438F-9F38-A08C29BEDD76Q28263096-E9B0D73B-B8A8-4ACC-95BD-EEF15B015460Q28303627-FA9707CB-B9A0-45A7-9BC0-FCDDEB826721Q28647292-F9A40FAC-46D9-48DE-A7C3-0CFE3FD11B99Q33264769-67C82902-3CC4-4AA0-BD5F-610F89A6CF78Q34494093-D3277F25-DADF-4264-80C9-930C9E33D818Q34499286-6EACF0FC-BA31-4EBE-80B2-1E6D1049AA49Q34634415-814247DF-7AD8-44AB-AAF5-A155B613A65EQ34826941-0C54800D-CDC6-4327-A8C7-558FDB8B0D73Q36214204-BD2D7F8A-E984-44DA-8522-FCB3512E26BDQ36700065-741B8565-F707-45B3-8368-A10837A48906Q36728029-F22DDC5B-2D4F-4C4A-92F8-62892F29202CQ36828943-80B9C72F-2FE9-4A51-BB12-1ED2E545AB02Q37359070-1A4CF73A-3442-494C-AC0C-99F9E436A24CQ37729053-12A713EC-9B43-4F5A-822C-8402E9DC4D33Q39534908-0C7FB530-58EF-4043-BE4D-C467D3CD5EBBQ39638322-8C2993A8-B2B0-42E9-98E2-D3B358945706Q39740759-40641433-75D8-4001-820F-517CBF3CD46BQ40104776-9EF1249B-DCC2-457D-BBA3-17FF27070091Q42028679-0A1F147A-494C-4823-9E5B-EB871FE35512Q42315898-8D8ACC24-DBAD-41A1-A850-68D9A69AF867Q42458669-F66FA76B-B1B2-4E9F-AF07-B3A25C8CD483Q42501870-06181510-8215-4C9B-BD39-A4E18EA0E46DQ43912115-60AE8FCC-F1AF-4CD6-9DAA-A9A853A0595AQ47100461-274B1D4A-4CAF-421D-A137-001D7A022E63Q47387894-B507D8E4-DF6F-4337-AC0F-EC7221EC8FE8Q48096667-48D3EBC1-021F-46A4-AD80-8FF0B12BDC09Q48145102-32ED9ACC-D855-4FF8-81E7-DC5D5E0316FCQ49906536-04A25424-BF26-4C64-8120-4B078A3544FCQ49906589-09D76F3D-1A79-4CB7-9355-C432E0FECBF0Q52579319-10C106C1-3F86-4F2B-A400-D20846922C67Q53151610-11A24EF6-D377-4C9F-8878-C2092C11B414Q53157078-B9E1F652-D471-4D0D-B299-2ED34AECA291Q54453103-39FF8962-6FD6-47CD-A6E9-C4AA79CA4115Q55428949-2F3BDF04-769F-481F-9E38-4C76A050A97CQ57253458-BDD2A21E-31E0-4570-9092-E77945F54BE6Q58777669-85B3CBA6-CAB1-45A3-8963-38B109A8ED67
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Mechanisms of blister induction by autoantibodies.
@ast
Mechanisms of blister induction by autoantibodies.
@en
type
label
Mechanisms of blister induction by autoantibodies.
@ast
Mechanisms of blister induction by autoantibodies.
@en
prefLabel
Mechanisms of blister induction by autoantibodies.
@ast
Mechanisms of blister induction by autoantibodies.
@en
P2860
P1476
Mechanisms of blister induction by autoantibodies.
@en
P2093
Cassian Sitaru
P2860
P304
P356
10.1111/J.1600-0625.2005.00367.X
P577
2005-12-01T00:00:00Z